216 related articles for article (PubMed ID: 37884534)
21. Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
Chan YH; Teo TH; Torres-Ruesta A; Hartimath SV; Chee RS; Khanapur S; Yong FF; Ramasamy B; Cheng P; Rajarethinam R; Robins EG; Goggi JL; Lum FM; Carissimo G; Rénia L; Ng LFP
Front Immunol; 2020; 11():894. PubMed ID: 32477364
[TBL] [Abstract][Full Text] [Related]
22. O'nyong-nyong fever: a neglected mosquito-borne viral disease.
Rezza G; Chen R; Weaver SC
Pathog Glob Health; 2017 Sep; 111(6):271-275. PubMed ID: 28829253
[TBL] [Abstract][Full Text] [Related]
23. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
Front Immunol; 2020; 11():591885. PubMed ID: 33224148
[TBL] [Abstract][Full Text] [Related]
24. NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation.
Dominguez F; Shiliaev N; Lukash T; Agback P; Palchevska O; Gould JR; Meshram CD; Prevelige PE; Green TJ; Agback T; Frolova EI; Frolov I
J Virol; 2021 Jul; 95(16):e0083621. PubMed ID: 34076483
[TBL] [Abstract][Full Text] [Related]
25. Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo.
Raulino R; Thaurignac G; Butel C; Villabona-Arenas CJ; Foe T; Loul S; Ndimbo-Kumugo SP; Mbala-Kingebeni P; Makiala-Mandanda S; Ahuka-Mundeke S; Kerkhof K; Delaporte E; Ariën KK; Foulongne V; Mpoudi Ngole E; Peeters M; Ayouba A
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009028. PubMed ID: 33476338
[TBL] [Abstract][Full Text] [Related]
26. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
27. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
Partidos CD; Paykel J; Weger J; Borland EM; Powers AM; Seymour R; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2012 Jun; 30(31):4638-43. PubMed ID: 22583812
[TBL] [Abstract][Full Text] [Related]
28. Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes.
Vanlandingham DL; Hong C; Klingler K; Tsetsarkin K; McElroy KL; Powers AM; Lehane MJ; Higgs S
Am J Trop Med Hyg; 2005 May; 72(5):616-21. PubMed ID: 15891138
[TBL] [Abstract][Full Text] [Related]
29. Determinants of vector specificity of o'nyong nyong and chikungunya viruses in Anopheles and Aedes mosquitoes.
Vanlandingham DL; Tsetsarkin K; Klingler KA; Hong C; McElroy KL; Lehane MJ; Higgs S
Am J Trop Med Hyg; 2006 Apr; 74(4):663-9. PubMed ID: 16607002
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis.
Assunção-Miranda I; Cruz-Oliveira C; Da Poian AT
Biomed Res Int; 2013; 2013():973516. PubMed ID: 24069610
[TBL] [Abstract][Full Text] [Related]
31. Multiple Host Factors Interact with the Hypervariable Domain of Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific Mode.
Meshram CD; Agback P; Shiliaev N; Urakova N; Mobley JA; Agback T; Frolova EI; Frolov I
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899097
[TBL] [Abstract][Full Text] [Related]
32. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus.
Pezzi L; Rodriguez-Morales AJ; Reusken CB; Ribeiro GS; LaBeaud AD; Lourenço-de-Oliveira R; Brasil P; Lecuit M; Failloux AB; Gallian P; Jaenisch T; Simon F; Siqueira AM; Rosa-Freitas MG; Vega Rua A; Weaver SC; Drexler JF; Vasilakis N; de Lamballerie X ;
Antiviral Res; 2019 Dec; 172():104610. PubMed ID: 31545981
[No Abstract] [Full Text] [Related]
33. O'nyong nyong virus molecular determinants of unique vector specificity reside in non-structural protein 3.
Saxton-Shaw KD; Ledermann JP; Borland EM; Stovall JL; Mossel EC; Singh AJ; Wilusz J; Powers AM
PLoS Negl Trop Dis; 2013; 7(1):e1931. PubMed ID: 23359824
[TBL] [Abstract][Full Text] [Related]
34. Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.
Tuekprakhon A; Puiprom O; Sasaki T; Michiels J; Bartholomeeusen K; Nakayama EE; Meno MK; Phadungsombat J; Huits R; Ariën KK; Luplertlop N; Shioda T; Leaungwutiwong P
PLoS One; 2018; 13(12):e0208851. PubMed ID: 30557365
[TBL] [Abstract][Full Text] [Related]
35. G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
Wang S; Merits A
J Virol; 2022 Nov; 96(21):e0127822. PubMed ID: 36226983
[TBL] [Abstract][Full Text] [Related]
36. A New Host Factor Essential for Chikungunya Virus.
Schnierle BS
Trends Microbiol; 2020 Jan; 28(1):2-4. PubMed ID: 31780232
[TBL] [Abstract][Full Text] [Related]
37. Applications of animal models of infectious arthritis in drug discovery: a focus on alphaviral disease.
Herrero L; Nelson M; Bettadapura J; Gahan ME; Mahalingam S
Curr Drug Targets; 2011 Jun; 12(7):1024-36. PubMed ID: 21366516
[TBL] [Abstract][Full Text] [Related]
38. Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate.
Chan YH; Teo TH; Utt A; Tan JJ; Amrun SN; Abu Bakar F; Yee WX; Becht E; Lee CY; Lee B; Rajarethinam R; Newell E; Merits A; Carissimo G; Lum FM; Ng LF
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31015278
[TBL] [Abstract][Full Text] [Related]
39. Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.
Taylor A; Melton JV; Herrero LJ; Thaa B; Karo-Astover L; Gage PW; Nelson MA; Sheng KC; Lidbury BA; Ewart GD; McInerney GM; Merits A; Mahalingam S
J Virol; 2016 Apr; 90(8):4150-4159. PubMed ID: 26865723
[TBL] [Abstract][Full Text] [Related]
40. CXCL10 Signaling Contributes to the Pathogenesis of Arthritogenic Alphaviruses.
Lin T; Geng T; Harrison AG; Yang D; Vella AT; Fikrig E; Wang P
Viruses; 2020 Nov; 12(11):. PubMed ID: 33147869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
